Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells

References

• Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 2009;9:465–479.10.1038/nri2569
   PubMed Web of Science ®Google Scholar
• Keler T, Ramakrishna V, Fanger MW. Mannose receptor-targeted vaccines. Expert Opin. Biol. Ther. 2004;4:1953–1962.10.1517/14712598.4.12.1953
   PubMed Web of Science ®Google Scholar
• Irache JM, Salman HH, Gamazo C, Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin. Drug Deliv. 2008;5:703–724.10.1517/edd.2008.5.issue-6
   PubMed Web of Science ®Google Scholar
• Deng Z, Li S, Jiang X, Narain R. Well-defined galactose-containing multi-functional copolymers and glyconanoparticles for biomolecular recognition processes. Macromolecules. 2009;42:6393–6405.10.1021/ma9010457
   Web of Science ®Google Scholar
• Song EH, Osanya AO, Petersen CA, Pohl NL. Synthesis of multivalent tuberculosis and Leishmania-associated capping carbohydrates reveals structure-dependent responses allowing immune evasion. J. Am. Chem. Soc. 2010;132:11428–11430.10.1021/ja103351m
   PubMed Web of Science ®Google Scholar
• Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, Lanzavecchia A, Pieters J. The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur. J. Immunol. 1997;27:2417–2425.10.1002/(ISSN)1521-4141
   PubMed Web of Science ®Google Scholar
• Upham JP, Pickett D, Irimura T, Anders EM, Reading PC. Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry. J. Virol. 2010;84:3730–3737.10.1128/JVI.02148-09
   PubMed Web of Science ®Google Scholar
• Jiang HL, Kang ML, Quan JS, Kang SG, Akaike T, Yoo HS, Cho CS. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization. Biomaterials. 2008;29:1931–1939.10.1016/j.biomaterials.2007.12.025
   PubMed Web of Science ®Google Scholar
• Figdor CG, van Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2002;2:77–84.10.1038/nri723
   PubMed Web of Science ®Google Scholar
• Cambi A, Figdor CG. Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell Biol. 2003;15:539–546.10.1016/j.ceb.2003.08.004
   PubMed Web of Science ®Google Scholar
• Stahl PD. The mannose receptor and other macrophage lectins. Curr. Opin. Immunol. 1992;4:49–52.10.1016/0952-7915(92)90123-V
   PubMed Web of Science ®Google Scholar
• Pyż E, Marshall AS, Gordon S, Brown GD. C-type lectin-like receptors on myeloid cells. Ann. Med. 2006;38:242–251.10.1080/07853890600608985
   PubMed Web of Science ®Google Scholar
• Chehimi J, Luo Q, Azzoni L, Shawver L, Ngoubilly N, June R, Jerandi G, Farabaugh M, Montaner LJ. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages. J. Leukoc. Biol. 2003;74:757–763.10.1189/jlb.0503231
   PubMed Web of Science ®Google Scholar
• Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology. 2010;7:34.10.1186/1742-4690-7-34
   PubMed Web of Science ®Google Scholar
• Gringhuis SI, van der Vlist M, van den Berg LM, den Dunnen J, Litjens M, Geijtenbeek TB. HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat. Immunol. 2010;11:419–426.10.1038/ni.1858
   PubMed Web of Science ®Google Scholar
• Mascola JR, Montefiori DC. The role of antibodies in HIV vaccines. Annu. Rev. Immunol. 2010;28:413–444.10.1146/annurev-immunol-030409-101256
   PubMed Web of Science ®Google Scholar
• Zolla-Pazner S. Identifying epitopes of HIV-1 that induce protective antibodies. Nat. Rev. Immunol. 2004;4:199–210.10.1038/nri1307
   PubMed Web of Science ®Google Scholar
• UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: United Nations; 2010.
   Google Scholar
• McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 2010;10:11–23.10.1038/nri2674
   PubMed Web of Science ®Google Scholar
• Catalfamo M, Di Mascio M, Hu Z, Srinivasula S, Thaker V, Adelsberger J, Rupert A, Baseler M, Tagaya Y, Roby G, Rehm C, Follmann D, Lane HC. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc. Natl. Acad. Sci. U.S.A. 2008;105:19851–19856.10.1073/pnas.0810032105
   PubMed Web of Science ®Google Scholar
• Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat. Rev. Microbiol. 2008;6:143–155.
   PubMed Web of Science ®Google Scholar
• Nguyen DG, Hildreth JE. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 2003;33:483–493.10.1002/immu.200310024
   PubMed Web of Science ®Google Scholar
• Sol-Foulon N, Moris A, Nobile C, Boccaccio C, Engering A, Abastado JP, Heard JM, van Kooyk Y, Schwartz O. HIV-1 NEF-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity. 2002;16:145–155.10.1016/S1074-7613(02)00260-1
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587–597.10.1016/S0092-8674(00)80694-7
   PubMed Web of Science ®Google Scholar
• Chung NP, Matthews K, Klasse PJ, Sanders RW, Moore JP. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells. J. Immunol. 2012;189:5257–5265.
   PubMed Web of Science ®Google Scholar
• Scanlan CN, Offer J, Zitzmann N, Dwek RA. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature. 2007;446:1038–1045.10.1038/nature05818
   PubMed Web of Science ®Google Scholar
• Shi W, Bohon J, Han DP, Habte H, Qin Y, Cho MW, Chance MR. Structural characterization of HIV gp41 with the membrane-proximal external region. J. Biol. Chem. 2010;285:24290–24298.10.1074/jbc.M110.111351
   PubMed Web of Science ®Google Scholar
• Conix A. Poly[1,3-bis(p-carboxyphenoxy)-propane anhydride]. Macromol. Synth. 1966;2:95–98.
   Google Scholar
• Kumar N, Langer RS, Domb AJ. Polyanhydrides: an overview. Adv. Drug Deliv. Rev. 2002;54:889–910.10.1016/S0169-409X(02)00050-9
   PubMed Web of Science ®Google Scholar
• Torres MP, Vogel BM, Narasimhan B, Mallapragada SK. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms. J. Biomed. Mater. Res. A. 2006;76A:102–110.10.1002/(ISSN)1552-4965
   Google Scholar
• Petersen LK, Sackett CK, Narasimhan B. High-throughput analysis of protein stability in polyanhydride nanoparticles. Acta Biomater. 2010;6:3873–3881.10.1016/j.actbio.2010.04.004
   PubMed Web of Science ®Google Scholar
• Carrillo-Conde B, Schiltz E, Yu J, Chris Minion F, Phillips GJ, Wannemuehler MJ, Narasimhan B. Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens. Acta Biomater. 2010;6:3110–3119.10.1016/j.actbio.2010.01.040
   PubMed Web of Science ®Google Scholar
• Ulery BD, Kumar D, Ramer-Tait AE, Metzger DW, Wannemuehler MJ, Narasimhan B. Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases. PLoS One. 2011;6:e17642. doi:17610.11371/journal.pone.0017642.10.1371/journal.pone.0017642
   PubMed Web of Science ®Google Scholar
• Kipper MJ, Wilson JH, Wannemuehler MJ, Narasimhan B. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism. J. Biomed Mater. Res. A. 2006;76A:798–810.10.1002/(ISSN)1552-4965
   Web of Science ®Google Scholar
• Ulery BD, Petersen LK, Phanse Y, Kong CS, Broderick SR, Kumar D, Ramer-Tait AE, Carrillo-Conde B, Rajan K, Wannemuehler MJ, Bellaire BH, Metzger DW, Narasimhan B. Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants. Sci. Rep. 2011;1:198. doi:10.1038/srep00198.
   PubMed Web of Science ®Google Scholar
• Penn-Nicholson A, Han DP, Kim SJ, Park H, Ansari R, Montefiori DC, Cho MW. Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope. Virology. 2008;372:442–456.10.1016/j.virol.2007.11.009
   PubMed Web of Science ®Google Scholar
• Gaiha GD, Dong T, Palaniyar N, Mitchell DA, Reid KB, Clark HW. Surfactant protein A binds to HIV and inhibits direct infection of CD4+ cells, but enhances dendritic cell-mediated viral transfer. J. Immunol. 2008;181:601–609.10.4049/jimmunol.181.1.601
   PubMedGoogle Scholar
• Fantuzzi L, Canini I, Belardelli F, Gessani S. HIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J. Immunol. 2001;166:5381–5387.10.4049/jimmunol.166.9.5381
   PubMedGoogle Scholar
• Shan M, Klasse PJ, Banerjee K, Dey AK, Iyer SP, Dionisio R, Charles D, Campbell-Gardener L, Olson WC, Sanders RW, Moore JP. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 2007;3:e169.10.1371/journal.ppat.0030169
   PubMed Web of Science ®Google Scholar
• Shen E, Pizsczek R, Dziadul B, Narasimhan B. Microphase separation in bioerodible copolymers for drug delivery. Biomaterials. 2001;22:201–210.10.1016/S0142-9612(00)00175-7
   PubMed Web of Science ®Google Scholar
• Torres MP, Wilson-Welder JH, Lopac SK, Phanse Y, Carrillo-Conde B, Ramer-Tait AE, Bellaire BH, Wannemuehler MJ, Narasimhan B. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation. Acta Biomater. 2011;7:2857–2864.10.1016/j.actbio.2011.03.023
   PubMed Web of Science ®Google Scholar
• Kipper MJ, Shen E, Determan A, Narasimhan B. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials. 2002;23:4405–4412.10.1016/S0142-9612(02)00181-3
   PubMed Web of Science ®Google Scholar
• Ulery BD, Phanse Y, Sinha A, Wannemuehler MJ, Narasimhan B, Bellaire BH. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres. Pharm. Res. 2009;26:683–690.10.1007/s11095-008-9760-7
   PubMed Web of Science ®Google Scholar
• Jaipuri FA, Pohl NL. Toward solution-phase automated iterative synthesis: fluorous-tag assisted solution-phase synthesis of linear and branched mannose oligomers. Org. Biomol. Chem. 2008;6:2686–2691.10.1039/b803451f
   PubMed Web of Science ®Google Scholar
• Curran DP, Luo Z. Fluorous synthesis with fewer fluorines (light fluorous synthesis): separation of tagged from untagged products by solid-phase extraction with fluorous reverse-phase silica gel. J. Am. Chem. Soc. 1999;121:9069–9072.10.1021/ja991496r
   Web of Science ®Google Scholar
• Zhang W. Fluorous linker-facilitated chemical synthesis. Chem. Rev. 2009;109:749–795.10.1021/cr800412s
   PubMed Web of Science ®Google Scholar
• Zhang W, Curran DP. Synthetic applications of fluorous solid-phase extraction (F-SPE). Tetrahedron. 2006;62:11837–11865.10.1016/j.tet.2006.08.051
   PubMed Web of Science ®Google Scholar
• Carrillo-Conde B, Song EH, Chavez-Santoscoy A, Phanse Y, Ramer-Tait AE, Pohl NL, Wannemuehler MJ, Bellaire BH, Narasimhan B. Mannose-functionalized “pathogen-like” polyanhydride nanoparticles target C-type lectin receptors on dendritic cells. Mol. Pharm. 2011;8:1877–1886.10.1021/mp200213r
   PubMed Web of Science ®Google Scholar
• Chavez-Santoscoy AV, Roychoudhury R, Pohl NL, Wannemuehler MJ, Narasimhan B, Ramer-Tait AE. Tailoring the immune response by targeting C-type lectin receptors on alveolar macrophages using ‘pathogen-like’ amphiphilic polyanhydride nanoparticles. Biomaterials. 2012;33:4762–4772.10.1016/j.biomaterials.2012.03.027
   PubMed Web of Science ®Google Scholar
• Carrillo-Conde BR, Roychoudhury R, Chavez-Santoscoy AV, Narasimhan B, Pohl NL. High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles. J. Vis. Exp. 2012;64:e3884. doi:10.3791/3884.
   Google Scholar
• Phanse Y, Carrillo-Conde BR, Ramer-Tait AE, Roychoudhury R, Pohl NL, Narasimhan B, Wannemuehler MJ, Bellaire BH. Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells. Acta Biomater. 2013;9:8902–8909.10.1016/j.actbio.2013.06.024
   PubMed Web of Science ®Google Scholar
• Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, Lee YC. Carbohydrate analysis by a phenol-sulfuric acid method in microplate format. Anal. Biochem. 2005;339:69–72.10.1016/j.ab.2004.12.001
   PubMed Web of Science ®Google Scholar
• Lopac SK, Torres MP, Wilson-Welder JH, Wannemuehler MJ, Narasimhan B. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres. J. Biomed. Mater. Res. B Appl. Biomater. 2009;91B:938–947.10.1002/jbm.b.v91b:2
   Google Scholar
• Torres MP, Determan AS, Anderson GL, Mallapragada SK, Narasimhan B. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials. 2007;28:108–116.10.1016/j.biomaterials.2006.08.047
   PubMed Web of Science ®Google Scholar
• Carrillo-Conde BR, Ramer-Tait AE, Wannemuehler MJ, Narasimhan B. Chemistry-dependent adsorption of serum proteins onto polyanhydride microparticles differentially influences dendritic cell uptake and activation. Acta Biomater. 2012;8:3618–3628.10.1016/j.actbio.2012.06.001
   PubMed Web of Science ®Google Scholar
• Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, Gruber G, Tauer C, Steindl F, Jungbauer A, Katinger H. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein–Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res. Hum. Retroviruses. 1994;10:359–369.10.1089/aid.1994.10.359
   PubMed Web of Science ®Google Scholar
• Purtscher M, Trkola A, Grassauer A, Schulz PM, Klima A, Döpper S, Gruber G, Buchacher A, Muster T, Katinger H. Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS. 1996;10:587–593.10.1097/00002030-199606000-00003
   PubMed Web of Science ®Google Scholar
• Purtscher M, Trkola A, Gruber G, Buchacher A, Predl R, Steindl F, Tauer C, Berger R, Barrett N, Jungbauer A, Katinger H. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 1994;10:1651–1658.10.1089/aid.1994.10.1651
   PubMed Web of Science ®Google Scholar
• Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 2007;81:4033–4043.10.1128/JVI.02588-06
   PubMed Web of Science ®Google Scholar
• Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F, Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses. 2001;17:1757–1765.10.1089/08892220152741450
   PubMed Web of Science ®Google Scholar
• Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 2001;75:10892–10905.10.1128/JVI.75.22.10892-10905.2001
   PubMed Web of Science ®Google Scholar
• Petersen LK, Xue L, Wannemuehler MJ, Rajan K, Narasimhan B. The simultaneous effect of polymer chemistry and device geometry on the in vitro activation of murine dendritic cells. Biomaterials. 2009;30:5131–5142.10.1016/j.biomaterials.2009.05.069
   PubMed Web of Science ®Google Scholar
• Petersen LK, Ramer-Tait AE, Broderick SR, Kong CS, Ulery BD, Rajan K, Wannemuehler MJ, Narasimhan B. Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants. Biomaterials. 2011;32:6815–6822.10.1016/j.biomaterials.2011.05.063
   PubMed Web of Science ®Google Scholar
• Determan AS, Graham JR, Pfeiffer KA, Narasimhan B. The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres. J. Microencapsul. 2006;23:832–843.10.1080/02652040601033841
   PubMed Web of Science ®Google Scholar
• Petersen LK, Phanse Y, Ramer-Tait AE, Wannemuehler MJ, Narasimhan B. Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen. Mol. Pharm. 2012;9:874–882.10.1021/mp2004059
   PubMed Web of Science ®Google Scholar
• Adams EW, Ratner DM, Seeberger PH, Hacohen N. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells. Chembiochem. 2008;9:294–303.10.1002/(ISSN)1439-7633
   PubMedGoogle Scholar
• Turville S, Wilkinson J, Cameron P, Dable J, Cunningham AL. The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J. Leukoc. Biol. 2003;74:710–718.10.1189/jlb.0503208
   PubMed Web of Science ®Google Scholar
• Berzi A, Varga N, Sattin S, Antonazzo P, Biasin M, Cetin I, Trabattoni D, Bernardi A, Clerici M. Pseudo-mannosylated DC-SIGN ligands as potential adjuvants for HIV vaccines. Viruses. 2014;6:391–403.10.3390/v6020391
   PubMed Web of Science ®Google Scholar
• Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, Iwasaki A. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 2002;76:1866–1875.10.1128/JVI.76.4.1866-1875.2002
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Harman AN, Donaghy H. DC-SIGN ‘AIDS’ HIV immune evasion and infection. Nat. Immunol. 2007;8:556–558.10.1038/ni0607-556
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 2005;11:S45–S53.10.1038/nm1213
   PubMed Web of Science ®Google Scholar
• Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev. 2009;229:152–172.10.1111/imr.2009.229.issue-1
   PubMed Web of Science ®Google Scholar
• McKenzie EJ, Taylor PR, Stillion RJ, Lucas AD, Harris J, Gordon S, Martinez-Pomares L. Mannose receptor expression and function define a new population of murine dendritic cells. J. Immunol. 2007;178:4975–4983.10.4049/jimmunol.178.8.4975
   PubMed Web of Science ®Google Scholar
• Ohtani M, Iyori M, Saeki A, Tanizume N, Into T, Hasebe A, Totsuka Y, Shibata K. Involvement of suppressor of cytokine signalling-1-mediated degradation of MyD88-adaptor-like protein in the suppression of Toll-like receptor 2-mediated signalling by the murine C-type lectin SIGNR1-mediated signalling. Cell. Microbiol. 2012;14:40–57.10.1111/cmi.2012.14.issue-1
   PubMed Web of Science ®Google Scholar
• Lewis JS, Zaveri TD, Crooks CP 2nd, Keselowsky BG. Microparticle surface modifications targeting dendritic cells for non-activating applications. Biomaterials. 2012;33:7221–7232.10.1016/j.biomaterials.2012.06.049
   PubMed Web of Science ®Google Scholar
• Saunders SP, Barlow JL, Walsh CM, Bellsoi A, Smith P, McKenzie AN, Fallon PG. C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide. J. Immunol. 2010;184:2627–2637.10.4049/jimmunol.0901970
   PubMed Web of Science ®Google Scholar